Navigation Links
Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates
Date:2/3/2009

CAMBRIDGE, Mass., Feb. 3 /PRNewswire/ -- Abt Associates announced that Ricky Takai, Ph.D., has joined the company as Principal Associate. After a brief orientation to the firm, Dr. Takai will become the leader of the company's education work in September 2009. Dr. Takai brings his more than 20 years experience in the design and management of federal evaluation studies in the field of education to the company.

Most recently, Dr. Takai served as Associate Commissioner in the National Center for Education Evaluation and Regional Assistance, Institute of Education Sciences, U.S. Department of Education. In this role he was responsible for national evaluations of major federal education programs including Title I and IDEA. Prior to that, Dr. Takai served as the division director for program evaluation in the Planning and Evaluation Service. He has directed program evaluations in a wide range of education areas such as early reading, educational technology, professional development, math and science education, drug prevention, dropout prevention, high school reform, vocational and adult education, and postsecondary education. In addition, Dr. Takai has served as the Acting Assistant Secretary in the Office of Educational Research and Improvement and the Office of Vocational and Adult Education.

"Ricky's high level work in the field of education research and evaluation, as well as his knowledge of federal education initiatives over the last 20 years, make him a tremendous asset to our company broadly and our growing Education portfolio more specifically," said Kathleen Flanagan, Group Vice President for Domestic Policy at the company.

In 1996 and 2006, Dr. Takai received Presidential Rank Awards. Presidential Rank Awards are reserved for senior career federal employees who have a sustained record of professional, technical, and/or scientific achievement that is recognized throughout the agency and is acknowledged on a national or international level.

Dr. Takai holds a Ph.D. in sociology from Johns Hopkins University and a B.A. from Washington College.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; international organizations and national governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.


'/>"/>
SOURCE Abt Associates
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Celebrity Designer Ty Pennington to Host ADHD Experts on Call Program
3. Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
4. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
5. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
6. Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
7. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
8. Expert Cardiologist Joins Quintiles Medical Group
9. California IVF Experts Tap Ethics Committee for Guidance
10. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
11. International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Rotary Club. The event entitled “Stem Cells and Their Regenerative Powers,” ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):